Brain-derived neurotrophic factor in the brain of Xenopus laevis may act as a pituitary neurohormone together with mesotocin

Journal of Neuroendocrinology

Volumn 18, Issue 6, 2006, Pages 454-465

  Calle, M ^a   Wang, L ^a   Kuijpers, F J ^a   Cruijsen, P M J M ^a   Arckens, L ^b   Roubos, Eric W ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

MSH; Neuropeptides

Indexed keywords

AMPHIBIAN PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; GOLD; HYPOPHYSIS HORMONE; MESOTOCIN; NEUROHORMONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; BRAIN TISSUE; ELECTRON MICROSCOPY; HORMONAL REGULATION; HORMONE ACTION; HORMONE RELEASE; HYPOPHYSIS; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAGNOCELLULAR NUCLEUS; NERVE ENDING; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN SECRETION; SECRETORY GRANULE; TISSUE LEVEL; ULTRASTRUCTURE; XENOPUS LAEVIS;

ALPHA-MSH; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; IMMUNOHISTOCHEMISTRY; MEDIAN EMINENCE; MELANOCYTES; MICROSCOPY, IMMUNOELECTRON; NEUROTRANSMITTER AGENTS; OXYTOCIN; PITUITARY GLAND; PRESYNAPTIC TERMINALS; XENOPUS LAEVIS;

EID: 33646337403     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2006.01433.x     Document Type: Article

References (48)

1. Chao M, Hempstead B. P75 and Trk: A two-receptor system. TINS 1995; 18: 321-326.
2. Chao MV. Neurotrophins and their receptors: A convergence point for many signalling pathways. Nat Rev Neurosci 2003; 4: 299-309.
3. McAllister AK, Katz LC, Lo DC. Neurotrophins and synaptic plasticity. Annu Rev Neurosci 1999; 22: 295-318.
4. Kokaia Z, Bengzon J, Metsis M, Kokaia M, Persson H, Lindvall O. Coexpression of neurotrophins and their receptors in neurons of the central nervous system. Proc Natl Acad Sci USA 1993; 90: 6711-6715.
5. Radka SF, Holst PA, Fritsche M, Altar CA. Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain Res 1996; 709: 122-301.
6. Yamamoto H, Gurney ME. Human platelets contain brain-derived neurotrophic factor. J Neurosci 1990; 10: 3469-3478.
7. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002; 109: 143-148.
8. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, Nakazato M, Watanabe H, Shinoda N, Okada S, Iyo M. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003; 54: 70-75.
9. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998; 37: 1553-1561.
10. Paredes A, Romero C, Dissen GA, DeChiara TM, Reichardt L, Cornea A, Ojeda SR, Xu B. TrkB receptors are required for follicular growth and oocyte survival in the mammalian ovary. Dev Biol 2004; 267: 430-449.
11. Noga O, Englmann C, Hanf G, Grutzkau A, Seybold J, Kunkel G. The production, storage and release of the neurotrophins nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 by human peripheral eosinophils in allergics and non-allergics. Clin Exp Allergy 2003; 33: 649-564.
12. Kononen J, Sonia S, Persson H, Honkaniemi J, Hökfelt T, Pelto-Huikko M. Neurotrophins and their receptors in the rat pituitary gland. regulation of BDNF and trkB mRNA levels by adrenal hormones. Brain Res Mol Brain Res 1994; 27: 347-354.
13. Conner JM, Yan Q, Varon S. Distribution of brain-derived neurotrophic factor in the rat pituitary gland. Neuroreport 1996; 7: 1937-1940.
14. Hopker VH, Amoureux MC, Varon S. NGF and BDNF in the anterior pituitary lobe of adult rats. J Neurosci Res 1997; 49: 355-363.
15. Wang LC, Meijer HK, Humbel BM, Jenks BG, Roubos EW. Activity-dependent dynamics of coexisting BDNF, POMC and αMSH in melanotrope cells of Xenopus laevis. J Neuroendocrinol 2004; 16: 19-25.
16. Kramer BMR, Cruijsen PMJM, Ouwens DTWM, Coolen MW, Martens GJM, Roubos EW, Jenks BG. Evidence that brain-derived neurotrophic factor acts as an autocrine factor on pituitary melanotrope cells of Xenopus laevis. Endocrinology 2002; 143: 1337-1345.
17. Wang LC, Humbel BM, Roubos EW. High-pressure freezing followed by cryosubstitution as a tool for preserving high-quality ultrastructure and immunoreactivity in the Xenopus laevis pituitary gland. Brain Res Prot 2005; 15: 155-163.
18. 2+ oscillations, cyclic AMP, and secretion in melanotrope cells of Xenopus laevis via a Y1 receptor. Peptides 1995; 16: 889-895.
19. Rijk EPCT, van Strien FJC, Roubos EW. Demonstration of coexisting catecholamine (dopamine), amino acid (GABA), and peptide (NPY) involved in inhibition of melanotrope cell activity in Xenopus laevis: A quantitative ultrastructural, freeze-substitution immunocytochemical study. J Neurosci 1992; 12: 864-871.
20. Tuinhof R, Artero C, Fasolo A, Franzoni MF, Ten Donkelaar HJ, Wismans PG, Roubos EW. Involvement of retinohypothalamic input, suprachiasmatic nucleus, magnocellular nucleus and locus coeruleus in control of melanotrope cells of Xenopus laevis: A retrograde and anterograde tracing study. Neuroscience 1994; 61: 411-420.
21. Ubink R, Tuinhof R, Roubos EW. Identification of suprachiasmatic melanotrope-inhibiting neurons in Xenopus laevis: A confocal laser-scanning microscopy study. J Comp Neurol 1998; 397: 60-68.
22. Berghs CAFM, Tanaka S, Van Strien FJC, Kurabuchi S, Roubos EW. The secretory granule and pro-opiomelanocortin processing in Xenopus melanotrope cells during background adaptation. J Histochem Cytochem 1997; 45: 1673-1682.
23. Jenks BG, Leenders HJ, Martens GJM, Roubos EW. Adaptation physiology: the functioning of pituitary melanotrope cells during background adaptation of the amphibian Xenopus laevis. Zool Sci 1993; 10: 1-11.
24. Roubos EW. Background adaptation by Xenopus laevis: A model for studying neuronal information processing in the pituitary pars intermedia. Comp Biochem Physiol 1997; 118: 533-550.
25. Roubos EW, Scheenen WJJM, Jenks BG. Neuroendocrinology, from concepts and complexity to integration -the Xenopu s pars intermedia. In: Goos HJTh, Rastogi RK, Vaudry H, Pierantoni R, eds. Perspectives in Comparative Endocrinology. Bologna: Monduzzi Editore, 2001: 465-472.
26. Roubos EW, Scheenen WJJM, Cruijsen PMJM, Cornelisse LN, Leenders HJ, Jenks BG. New aspects of signal transduction in the Xenopus laevis melanotrope cell. Gen Comp Endocrinol 2002; 126: 255-260.
27. Kolk SM, Kramer BMR, Cornelisse LN, Scheenen WJJM, Jenks BG, Roubos EW. Multiple control and dynamic response of the Xenopus melanotrope cell. Comp Biochem Physiol B 2002; 132: 257-268.
28. Vandesande F, Dierickx K. Immunocytochemical demonstration of separate vasotocinergic and mesotocinergic neurons in the amphibian hypothalamic magnocellular neurosecretory system. Cell Tissue Res 1976; 175: 289-296.
29. Dierickx K, Vandesande F. Immuno-cytochemical demonstration in the external region of the amphibian median eminence, of separate vasotocinergic and mesotocinergic nerve fibres. Cell Tiss Res 1977; 177: 47-56.
30. van Vossel-Daeninck J, Dierickx K, van Vossel A, Vandesande F. Electron microscopic immunocytochemical demonstration of separate vasotocinergic and mesotocinergic nerve terminals in the median eminence of the frog hypophysis. Cell Tiss Res 1979; 204: 29-36.
31. González A, Smeets WJAJ. Distribution of vasotocin- and mesotocin-like immunoreactivities in the brain of the South African clawed frog Xenopus laevis. J Chem Neuroanat 1992; 5: 465-479.
32. Veburg van Kemenade BM, Jenks BG, Driessen AG. GABA and dopamine act directly on melanotropes of Xenopus to inhibit MSH secretion. Brain Res Bull 1986; 17: 697-704.
33. Rodriguez EM. Design and perspectives of peptide secreting neurons. In: Nemeroff CB, Dunn AJ, eds. Hormones and Behavior Peptides. New York, NY: Spectrum Publications, 1984: 1-6.
34. Pang PK, Sawyer WH. Renal and vascular responses of the bullfrog (Rana catesbeiana) to mesotocin. Am J Physiol 1978; 235: 151-155.
35. Warburg MR. Hormonal effect on the osmotic, electrolyte and nitrogen balance in terrestrial Amphibia. Zool Sci 1995; 12: 1-11.
36. Tonon MC, Cuet P, Lamacz M, Jégou S, Cote J, Gateaux L, Ling N, Pelletier G, Vaudry H. Comparative effects of corticotropin-releasing factor, arginine vasopressin, and related neuropeptides on the secretion of ACTH and alpha-MSH by frog anterior pituitary cells and neurointermediate lobes in vitro. Gen Comp Endocrinol 1986; 61: 438-445.
37. Lamacz M, Hindelang C, Tonon MC, Vaudry H, Stoeckel ME. Three distinct thyrotropin-releasing hormone-immunoreactive axonal systems project in the median eminence-pituitary complex of the frog Rana ridibunda. Immunocytochemical evidence for co-localization of thyrotropin-releasing hormone and mesotocin in fibers innervating pars intermedia cells. Neuroscience 1989; 32: 451-462.
38. Shioda S, Nakai Y, Iwai C, Sunayama H. Co-existence of TRH with mesotocin in the same axon terminals of the bullfrog pars nervosa as revealed by double labeling immunocytochemistry. Neurosci Lett 1989; 98: 25-28.
39. Vaudry H, Trochard MC, Leboulenger F, Vaillant R. Control of pituitary secretion of melanotropin in an anuran amphibian by thyrotropin releasing factor (TRH). Study in vitro. C R Acad Sci Hebd Séances Acad Sci D 1977; 284: 961-965.
40. Verburg-van Kemenade BML, Jenks BG, Visser TJ, Tonon MC, Vaudry H, 1987. Assessment of TRH as a potential αMSH-release stimulating factor in Xenopus laevis. Peptides 1987; 8: 69-76.
41. Galas L, Lamacz M, Garnier M, Roubos EW, Tonon MC, Vaudry H. Involvement of extracellular and intracellular calcium sources in TRH-induced alpha-MSH secretion from frog melanotrope cells. Mol Cell Endocrinol 1998; 138: 25-39.
42. Galas L, Lamacz M, Garnier M, Roubos EW, Tonon MC, Vaudry H. Involvement of protein kinase C and protein tyrosine kinase in thyrotropin-releasing hormone-induced stimulation of alpha-melanocyte-stimulating hormone secretion in frog melanotrope cells. Endocrinology 1999; 140: 3264-3272.
43. Verburg-van Kemenade BML, Jenks BG, Cruijsen PMJM, Dings A, Tonon MC, Vaudry H. Regulation of MSH release from the neurointermediate lobe of Xenopus laevis by CRF-like peptides. Peptides 1987; 8: 1093-1100.
44. Calle M, Corstens GJH, Wang LC, Kozicz T, Denver RJ, Barendregt HP, Roubos EW. Evidence that urocortin I acts as a neurohormone to stimulate αMSH release in the toad Xenopus laevis. Brain Res 2005; 1040: 14-28.
45. Conway KM, Gainer H. Immunocytochemical studies of vasotocin, mesotocin, and neurophysins in the Xenopus hypothalamo-neurohypophysial system. J Comp Neurol 1987; 264: 494-508.
46. González A, Muñoz A, Muñoz M, Marin O, Smeets WJAJ. Ontogeny of vasotocinergic and mesotocinergic systems in the brain of the South African clawed frog Xenopus laevis. J Chem Neuroanat 1995; 9: 27-40.
47. Tonosaki Y, Cruijsen PMJM, Nishiyama K, Yaginuma H, Roubos EW. Low temperature stimulates α-melanophore-stimulating hormone secretion and inhibits background adaptation in Xenopus laevis. J Neuroendocrinol 2004; 16: 894-905.
48. Givalois L, Arancibia S, Alonso G, Tapia-Arancibia L. Expression of BDNF and its receptors in the median eminence cells with sensitivity to stress. Endocrinology 2004; 145: 4737-4747.